Closing the regulatory regress: GMP accreditation in stem cell laboratories

Sociology of Health and Illness

Volumn 35, Issue 3, 2013, Pages 345-360

  Stephens, Neil ^a   Lewis, Jamie ^a   Atkinson, Paul ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Good manufacturing practice (GMP); Regress; Regulation; Stem cells; UK Stem Cell Bank

Indexed keywords

ACCREDITATION; BIOBANK; CULTURAL ANTHROPOLOGY; ETHICS; GREAT BRITAIN; HUMAN; LABORATORY; LEGISLATION AND JURISPRUDENCE; STEM CELL RESEARCH;

ACCREDITATION; ANTHROPOLOGY, CULTURAL; BIOLOGICAL SPECIMEN BANKS; GREAT BRITAIN; HUMANS; LABORATORIES; STEM CELL RESEARCH;

EID: 84875673870     PISSN: 01419889     EISSN: 14679566     Source Type: Journal    
DOI: 10.1111/j.1467-9566.2012.01482.x     Document Type: Article

References (35)

1. Akrich, M. (1992) The description of technical objects. In Bijker, W. and Law, J. (eds) Shaping Technology/Building Society: Studies in Sociotechnical Change. Cambridge, MA: MIT Press.
2. Appelbe, G.E. (2005) From arsenic to thalidomide: a brief history of medicine safety. In Anderson, S.C. (ed.) Making Medicines: A Brief History of Pharmacy and Pharmaceuticals. London: Pharmaceutical Press.
3. Brown, N. and Michael, M. (2003) A sociology of expectations: retrospecting prospects and prospecting retrospects, Technology Analysis & Strategic Management, 15, 1, 3-18.
4. Clarke, A., Mamo, L. and Fosker, J. (eds) (2010) Biomedicalization: Technoscience, Health and Illness in the US. Durham, NC: Duke University Press.
5. Collins, H. (1975) The seven sexes: a study in the sociology of the phenomenon, or the replication of experiments in physics, Sociology, 9, 2, 205-24.
6. Collins, H. (1985) Changing Order: Replication and Induction in Scientific Practice. Chicago, IL: University of Chicago Press.
7. Faulkner, A., Geesink, I., Kent, J. and FitzPatrick, D. (2003) Human tissue engineered products - drugs or devices?, British Medical Journal, 326, 1159-60.
8. Franklin, S. (2001) Culturing biology: cell lines for the new millennium, Health, 5, 3, 335-54.
9. Gene Therapy Advisory Committee (GTAC) (2009) Interim UK Regulatory Route Map for Stem Cell Research and Manufacture. Available at http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_097284.pdf (date last consulted 20 October 2009).
10. Haddow, G., Bruce, A., Calvert, J., Harmona, S. and Marsdena, A. (2010) Not 'human' enough to be human but not 'animal' enough to be animal - the case of the HFEA, cybrids and xenotransplantation in the UK, New Genetics and Society, 29, 1, 3-17.
11. Hammond-Browning, N. and Stephens, N. (in press) Moving human embryonic stem cells internationally: near-future challenges for the UK Stem Cell Bank and American collaborators. In Priaulx, N. and Wrigley, A. (eds) Ethics, Law and Society, Vol 5. Farnham, Surrey: Ashgate Publishing.
12. Hutter, B.M. (2006) The Role of Non-State Actors in Regulation. Discussion Paper No. 37. London: London School of Economics and Political Science (LSE).
13. Jasanoff, S. (2005) Designs on Nature Princeton. Princeton, NJ: Princeton University Press.
14. Jordan, K. and Lynch, M. (1998) The dissemination, standardization and routinization of a molecular biological technique, Social Studies of Science, 28, 5/6, 773-800.
15. Kent, J. (2008) The fetal tissue economy: from the abortion clinic to the stem cell laboratory, Social Science & Medicine, 67, 11, 1747-56.
16. Lewis, J. and Atkinson, P. (2011) The surveillance of cellular scientists' practice, BioSocieties, 6, 4, 381-400.
17. Martin, P., Brown, N. and Kraft, A. (2008) From bedside to bench? Communities of promise, translational research and the making of blood stem cells, Science as Culture, 17, 29-41.
18. Medicines and Healthcare Products Regulatory Agency (MHRA) (2008) Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2007 - The 'Orange Guide'. Available at http://www.mhra.gov.uk/Publications/Regulatoryguidance/Medicines/CON2030291 (date last consulted 29 October 2008).
19. Oudshoorn, N. and Pinch, T. (2003) How Users Matter: The Co-construction of Users and Technology. Cambridge, MA: MIT Press.
20. Pfeffer, N. (2009) How work reconfigures an unwanted pregnancy into 'the right tool for the job' in stem cell research, Sociology of Health and Illness, 31, 1, 98-111.
21. Pfeffer, N. and Kent, J. (2007) Framing women, framing fetuses: how Britain regulates arrangements for the collection and use of aborted foetuses in stem cell research and therapies, BioSocieties, 2, 4, 429-47.
22. Pinch, T. and Bijker, W. (1984) The social construction of facts and artefacts: or how the sociology of science and the sociology of technology might benefit each other, Social Studies of Science, 14, 399-441.
23. Rothstein, H., Irwin, A., Yearley, S. and McCarthy, E. (1999) Regulatory science, Europeanisation and the control of agrochemicals, Science, Technology and Human Values, 27, 241-64.
24. Stacey, G. (2004) First Report from the UK Stem Cell Bank. Potters Bar: National Institute for Biological Standards and Control.
25. Stacey, G. and Stephens, N. (2012) Social science in a stem cell laboratory: what happened when social and life sciences met, Regenerative Medicine, 7, 117-26.
26. Stephens, N., Atkinson, P. and Glasner, P. (2008a) The UK Stem Cell Bank: securing the past, validating the present, protecting the future, Science as Culture, 17, 43-56.
27. Stephens, N., Atkinson, P. and Glasner, P. (2008b) The UK Stem Cell Bank as performative architecture, New Genetics and Society, 27, 87-99.
28. Stephens, N., Atkinson, P. and Glasner, P. (2011a) Documenting the doable and doing the documented: bridging strategies at the UK Stem Cell Bank, Social Studies of Science, 41, 791-813.
29. Stephens, N., Atkinson, P. and Glasner, P. (2011b) Internationaliser des standards, metter en banquet avec confiance: la mise en banquet de cellules souches s trois systèmes nationaux, Revue d'Anthropologie des Connaissances, 5, 260-86.
30. Wainwright, S.P. (2005) Can stem cells cure Parkinson's disease? Embryonic steps toward a regenerative brain medicine, British Journal of Neuroscience Nursing, 1, 61-6.
31. Wainwright, S.P., Williams, C., Michael, M., Farsides, B. and Cribb, A. (2006) From bench to bedside? Biomedical scientists' expectations of stem cell science as a future therapy for diabetes, Social Science & Medicine, 63, 2052-64.
32. Waldby, C. (2002) Stem cells, tissue cultures and the production of biovalue, Health, 6, 3, 305-23.
33. Winch, P. (1958) The Idea of a Social Science and its Relation to Philosophy. London: Routledge & Kegan Paul.
34. Wittgenstein, L. (1953) Philosophical Investigations. Editors: Anscombe, G.E.M. (trans.) and Rhees, R. Oxford: Blackwell.
35. Zarzeczny, A., Scott, C., Hyun, I., Bennett, J., et al. (2009) iPS cells: mapping the policy issues, Cell, 139, 1032-7.